Would you like to learn more about organs-on-chip? How to use them in preclinical research? Why they are a valuable alternative to animal testing? And much more? 🎧 Don’t hesitate and listen to the 1h Podcast of our CEO, Dr. Nina Hobi, on X-health.show! Link A big thank you to Alex Jani for this episode…

🚀 Do you want to know how AlveoliX makes the quantum leap to replace unneeded animal testing? Watch the full story: Here! 🙏 Thanks to our peers and quantum pioneers from QuantumBasel and a special thanks to Julia Schwamborn SRF – Schweizer Radio und Fernsehen, NZZ for making such a complex and game-changing science topic accessible to…

🎉 Today, we take a moment to honor three exceptional individuals who have reached a milestone in their careers – their 5th work anniversary with us!🎂 🥳 Congratulations to Giulia Raggi, Andreas Hugi, and Stefan G. on this remarkable achievement! Your commitment, and hard work over the past five years as well as your smart,…

🎥We’re thrilled to share our feature in the latest video by LSCV – Ligue suisse contre l’expérimentation animale et pour les droits des animaux. We are answering crucial questions like: How can we do without animal experimentation? What methods can we use? And what about financial resources? 📰But wait, there’s more! Dive into the insightful…

📻 On the Radiotelevisione Svizzera Italiana (RSI) program “Millevoci”, our brilliant project manager Giulia Raggi discussed a thought-provoking topic close to our hearts: animal experiments and alternative models. If you’re curious about the future of testing methods, you won’t want to miss this insightful podcast! (IT) ⏩ Tune in to the podcast and catch Giulia’s…

👋 After the long pandemic, last week we could finally make it to Iceland to meet our colleagues at EpiEndo Pharmaceuticals face-to-face.The occasion was EPIColiX – a joint ground-breaking project aiming at developing a new gut-on-chip model for drug testing under the Eurostars program. ⚡️ We are very pleased about the achievements obtained so far in this…

🎉 Let’s start 2023 with good news: The FDA Modernization Act 2.0 has passed congress and is inked by President Biden! 🧫 This big achievement lets the FDA consider non-animal cutting-edge testing methods as standalone tests for preclinical studies, finally allowing the use Organs-on-Chip and NAMs for drug safety and efficacy assessment. 📑 𝘛𝘩𝘦 𝘍𝘋𝘈 𝘔𝘰𝘥𝘦𝘳𝘯𝘪𝘻𝘢𝘵𝘪𝘰𝘯 𝘈𝘤𝘵 2.0 𝘱𝘳𝘰𝘮𝘪𝘴𝘦𝘴 𝘵𝘰 𝘳𝘦𝘣𝘰𝘰𝘵 𝘢 𝘣𝘳𝘰𝘬𝘦𝘯 𝘥𝘳𝘶𝘨…